SnapMedsSnapMeds

Sofosbuvir
Sofosbuvir

29.21
Supports long-term hepatic recovery for Antivirals by inhibiting the NS5B RNA polymerase to dismantle the viral replication machinery and eradicate the circulating pathogen.
Ingredient
Sofosbuvir
Category
Antivirals
Availability
In Stock
Delivery Time
Airmail (14-21 days) | Trackable (5-9 days)
Shipped in a discreet, unmarked envelope with all required documents enclosed.

Product Sheet

Active Ingredient(s)
Sofosbuvir
Reference Brand
Sovaldi
Product Origin
Generic Product
Reference Manufacturer
Gilead Sciences
Product Form
Tablet
Regulatory Classification
Rx
Primary Category
Antivirals
Product Category
HCV NS5B inhibitor
Pharmacological Class
Direct-acting antiviral
Clinical Indications
Hepatitis C
Manufacturer Description
Developed to support the management of Hepatitis C, this agent is utilized to address viral load and support liver health.
Mechanism of Action
Sofosbuvir acts as a nucleotide analog inhibitor of the HCV NS5B polymerase. It is incorporated into the viral RNA chain, triggering chain termination and stopping viral replication within the liver cells.
Route of Administration
Oral
Onset Time
Rapid absorption
Duration
24 hours
Contraindications
Known hypersensitivity to components
Severe Adverse Events
Severe bradycardia when used with amiodarone
Common Side Effects
Fatigue, Headache
Uncommon Side Effects
Insomnia, Nausea
Drug Interactions
Amiodarone, St. John's wort
Pregnancy Safety Warnings
Use with caution; refer to pregnancy category for combination regimens.
Age Restrictions
Follow local prescribing guidelines.
Storage Guidelines
Store at room temperature in the original container.
Related Products
Velpatasvir, Ledipasvir

Sofosbuvir FAQ

How do digital health platforms facilitate evaluation and access to Sofosbuvir in Singapore?

Digital health platforms provide a mechanism for individuals to connect with healthcare providers for remote evaluation and document review, ensuring that access to Sofosbuvir aligns with established medical safety standards in Singapore.

Why are there cost variations between multi-source generic Sofosbuvir formulations and originator brands?

Cost differences arise from the economics of research, development, and manufacturing scale, where generic versions focus on providing bioequivalent chemical pathways without the initial expenditure attributed to the creation of the originator brand.

How can patients in Singapore verify the regulatory compliance and sourcing standards of digital health directories?

Patients can verify compliance by checking for verifiable evidence of source transparency and ensuring that the digital directory adheres to local health guidelines regarding the distribution of medication.

What are the logistical or regulatory considerations when utilizing cross-border facilitation for personal use?

Importing medication for personal use into Singapore requires strict adherence to HSA guidelines, including the necessity for documentation that validates the medical requirement and the regulatory status of the substance being imported.

How does clinical bioequivalence ensure that generic Sofosbuvir is effective compared to originator formulas?

Clinical bioequivalence confirms that the generic formulation delivers the same active ingredient to the systemic circulation at a rate and extent comparable to the originator, resulting in the same therapeutic effect within the body.

What is Sofosbuvir?

  • Viral replication in hepatocytes is inhibited by Sofosbuvir, a direct-acting antiviral nucleotide analog. Clinical protocols utilize this compound to address specific viral load burdens within the liver. Targeting the replication cycle of chronic viral infections, Sofosbuvir serves as a cornerstone in modern antiviral therapeutic regimens.

  • Pharmacological activity centers on the incorporation of the compound into the viral RNA chain. Cellular processes recognize this molecular mimic, resulting in the termination of the viral replication process. Efficiency in blocking these specific pathways makes the compound a primary choice for managing chronic infection.

  • Therapeutic regimens often integrate this molecule into multi-component cycles to enhance viral clearance rates. Management of chronic conditions requires precisely timed sequences of this antiviral agent. Consistent adherence to treatment protocols supports the body in reducing viral presence within the bloodstream.

Regulatory & Classification Profile

  • Regulatory classifications for Sofosbuvir in Singapore categorizes the compound as a Prescription-Only Medicine (POM). Oversight by the Health Sciences Authority (HSA) ensures that distribution and utilization remain within established clinical parameters. Access requires professional evaluation to ensure medical necessity and adherence to safety guidelines for patients.

Formulations & Associated Medications

  • Sofosbuvir functions as a bioequivalent generic formulation of the active ingredient Sofosbuvir. Manufacturing standards ensure that these generic agents mirror the efficacy and chemical profile of the originator compound. Available formulations accessible through digital health directories include Sofosbuvir pill in strengths of 400mg.

Therapeutic Applications

  • Management of chronic viral infections: Sofosbuvir addresses high-level viral persistence in the liver.
  • Reduction of viral load markers: The compound assists with lowering infectious counts during treatment cycles.
  • Support of standardized therapeutic regimens: Clinical use centers on patient populations currently undergoing structured viral control protocols.
  • Prevention of secondary hepatic complications: Appropriate utilization facilitates the stabilization of hepatocyte function by minimizing ongoing viral activity.

Biological Action

  • Viral reproduction depends on specific enzymes to replicate genetic material. Sofosbuvir mimics the building blocks necessary for this genetic construction. When the virus consumes this mimic during replication, the process halts prematurely. Consequently, the infection cannot produce new copies, allowing the biological system to clear existing viral loads over time.

Treatment Landscape & Drug Class

  • Nucleotide polymerase inhibitors represent the chemical family hosting Sofosbuvir. Modern medical protocols utilize this drug class to address systemic viral infections through targeted disruption of replication enzymes. Advances in this category have allowed for shorter, more focused therapeutic durations compared to previous generations of antiviral agents.

Understanding the Safety Profile

  • Physiological management of Sofosbuvir involves primary metabolic processes within hepatic pathways and subsequent elimination through the renal system. Central nervous system monitoring remains a standard component of patient observation during antiviral therapy. Clinical observation confirms that systemic integration varies based on individual biological metrics. Refer to the clinical data tables provided for specific contraindications, interactions, and potential reactions.

Clinical Disclosure

  • Provided information offers an educational overview of the antiviral compound Sofosbuvir. Diverse medicines like Sofosbuvir generic formulations exhibit variability in strength based on the specific manufacturing standards adopted. Users must acknowledge that third-party platforms do not assume medical liability for treatment outcomes. Professional consultation with a healthcare professional remains a mandatory requirement before initiating any therapeutic regimen, ensuring all labeling and safety instructions are thoroughly reviewed and correctly understood by the patient.

Clinical Glossary

Drug Class
A cohort of medications sharing similar chemical structures and functions for managing specific health conditions.
Bioequivalence
The biological similarity between a generic formulation and an originator compound, confirmed through standardized clinical testing.
Hepatocyte
A primary cell type found in the human liver that acts as a target site for both viral infection and antiviral therapy.
Nucleotide Analog
A chemical compound that structures itself to mimic the natural components of genetic material to disrupt viral reproduction.
Information associated with Sofosbuvir is curated and periodically reviewed using established medical references and prescribing guidelines. Content is intended for general awareness and should be verified with a licensed healthcare professional before use.
Categories